We identified significant methylation changes in the CpGs of two CYP genes (CYP51A1 and CYP2S1) that are involved in regulating processes, such as cholesterol metabolism, neurotoxicity, and drug metabolism, each of which appears to be important in AD. The gene discussed is CYP51A1; the disease is Alzheimer disease.